p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function

Endocrinology

Volumn 143, Issue 8, 2002, Pages 3105-3113

  Li, Xiaotong ^a   Udagawa, Nobuyuki ^a   Itoh, Kanami ^b   Suda, Koji ^b   Murase, Yoshiyuki ^c   Nishihara, Tatsuji ^d   Suda, Tatsuo ^e   Takahashi, Naoyuki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

^d KYUSHU DENTAL COLLEGE   (Japan)

^e SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALCITRIOL; I KAPPA B; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0036321005     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.8.8954     Document Type: Article

References (52)

1. Cell biology of the osteoclast
2. Bone resorption by osteoclasts
3. Regulation of the differentiation and function of osteoclasts
4. Interleukins in the control of osteoclast differentiation
5. Osteoblastic cells are involved in osteoclast formation
6. Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse
7. Modulation of osteoclast differentiation
8. Regulation of osteoclast development and function
9. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
10. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor
11. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse
12. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
13. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
14. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
15. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
16. Modulation of osteoclast differentiation and function by the new members of the rumor necrosis factor receptor and ligand families
17. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
18. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
19. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function
20. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase. Identification of a novel TRAF6 interaction motif
21. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-κB, a member of the TNFR superfamily
22. Receptor activator of NF-κB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase
23. The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor
24. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
25. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice
26. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis
27. Lipopolysaccharide supports and fusion of preosteoclasts independent of TNFα, IL-1 and RANKL
28. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells
29. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
30. Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts
31. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
32. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the LPS gene product
33. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
34. Requirement for NF-κB in osteoclast and B-cell development
35. Osteopetrosis in mice lacking NF-κB1 and NF-κB2
36. Bone and haematopoietic defects in mice lacking c-Fos
37. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
38. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
39. How MAP kinases are regulated
40. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
41. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
42. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κ B ligand (RANKL)
43. Inhibition of p38 MAP kinase as a therapeutic strategy
44. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase
45. Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli
46. Role of 1 α, 25-dihydroxyvitamin D3 in osteoclast differentiation and function
47. Preparation and characterization of a mouse osteoclast-like multinucleated cell population
48. Differentiation kinetics of osteoclasts in the periosteum of embryonic bones in vivo and in vitro
49. IL-6 is produced by osteoblasts and induces bone resorption
50. Activation of NF-κB is involved in the survival of osteoclasts promoted by interleukin-1
51. p38 mitogen-activated protein (MAP) kinase but not p44/p42 MAP kinase is involved in prostaglandin El-induced vascular endothelial growth factor synthesis in osteoblasts
52. p38 MAP kinase is involved in the signalling of sphingosine in osteoblasts: Sphingosine inhibits prostaglandin F(2α)-induced phosphoinositide hydrolysis